Statement

Africa, and Côte d'Ivoire in particular, cannot continue to depend on imports for more than 70% of its medicines.

Health sovereignty depends on local production.

It is an economic issue, but above all a strategic one.

We must build strong industrial capacities.

This is the fight I am leading today.

Dr Hervé OULAI Founder & Chairman, CPF · OVECH Capital Group
Dr Hervé Oulai, Founder of OVECH Capital

Founding Charter, Vision 2030

Our Purpose

"Born in Côte d'Ivoire, destined to become a leading African pharmaceutical group."

To sustainably improve the health of African populations by developing a local pharmaceutical industry that is efficient, innovative and accessible.

We believe Africa must progressively strengthen its capacity to manufacture the medicines, medical devices and healthcare solutions its people need.

We are committed to contributing to this industrial transformation and to the continent's health sovereignty, always placing patient safety at the forefront of our decisions.

What guides us

Our Core Values

  • Excellence

    Make quality, patient safety and performance permanent requirements.

  • Integrity

    Act ethically, transparently and loyally; honour our commitments; and comply without exception with regulatory requirements and Good Manufacturing Practices (GMP).

  • Innovation

    Encourage research, technology transfer, continuous improvement and industrial boldness.

  • Commitment

    Foster discipline, accountability, teamwork and a results-driven culture.

  • African Pride

    Believe in our people, develop African expertise and demonstrate that Africa can build a competitive pharmaceutical industry meeting international standards.

Group structure: 2 divisions, 5 entities

Our Group Structure

OVECH Capital is an industrial healthcare group. Pharmaceuticals are its core business, supported by two asset-based activities that strengthen its resilience and financial independence.

OVECH CapitalIndustrial healthcare group
Core business

Health Division

  • CPFPharmaceutical manufacturing, Bingerville
  • C2PPharmaceutical promotion and commercialisation
  • OVECH Pharma HubIntegrated industrial hub project, Aheremou 1 (under development)

The Health Division embodies our identity, our 2030 objectives and our presence in the pharmaceutical ecosystem.

Asset-backed

Asset-Backed Division

  • OVECH RanchPoultry production, Aheremou 1
  • SCI OVECHReal estate assets

The asset-backed activities secure the Group's land and property holdings, diversify income and preserve financial independence without equity dilution.

Both divisions uphold the same values and commitment to excellence.

2030 horizon

Our 2030 Ambition

To establish OVECH Capital as a benchmark industrial healthcare group in West and Central Africa, recognised for industrial excellence, product quality, innovation and international reach.

CFA 50 bnannual revenue targeted by 2030
9African export markets, in addition to Côte d'Ivoire

This ambition is built around four major objectives:

Growth

Achieve annual revenue of CFA francs 50 billion by 2030.

Export

Expand our commercial presence to nine African export markets, in addition to Côte d'Ivoire, drawing on our industrial capabilities based in Côte d'Ivoire.

Industrial hub

Develop the Aheremou 1 Pharmaceutical Hub into an integrated industrial centre progressively covering medicines, medical devices and hospital hygiene solutions.

Organisation

Build a high-performing, sustainable organisation rooted in African talent, responsible governance, financial discipline, leadership accountability and knowledge transfer.

The strategic vision

Building the pharmaceutical platform of West Africa

"Through OVECH Capital, Dr Hervé Oulai carries a major strategic ambition: to build an integrated pharmaceutical industrial platform in West Africa, in order to reduce the continent's dependence on imported medicines and strengthen its health sovereignty."

Africa today imports more than 80% of its medicines. This structural dependence weakens health systems, raises the cost of care and exposes populations to supply shortages. Dr Hervé Oulai has made it the central challenge of his work.

Building on its experience at the head of CPF, Consulting Pharma Formulations, OVECH Capital aims to consolidate and extend this industrial momentum at regional scale.

Visit ovechcapital.com
CPF Consulting Pharma Formulations plant in Bingerville, industrial pharmaceutical production in Côte d'Ivoire

CPF plant in Bingerville, 3,000 m² of pharmaceutical production, Côte d'Ivoire

108
Marketing Authorisations
3
Active production lines
17
Countries of distribution
3,000 m²
Modern plant in Bingerville

The industrial tool

CPF, Consulting Pharma Formulations

Founded in January 2009 by Dr Hervé Oulai, Consulting Pharma Formulations (CPF) is today one of the best-structured pharmaceutical companies in Côte d'Ivoire. It is the main industrial vehicle of the OVECH Capital vision.

Based in a modern 3,000 m² plant in Bingerville, CPF has three production lines enabling the manufacture of medicines in solid forms (tablets, capsules), liquid and semi-solid forms.

With 108 Marketing Authorisations obtained from health authorities, CPF markets its products in 17 countries of sub-Saharan Africa, directly contributing to access to essential medicines in the region.

Visit cpf-afrique.com

CPF in figures

  • 108 Approved Marketing Authorisations
  • 192 Trained and committed employees
  • 17 Countries of presence in sub-Saharan Africa
  • 3 Active production lines in Bingerville
  • 3,000 m² of modern plant floor area

Founding Charter, Vision 2030

Our Shared Commitment

At OVECH Capital, every employee, regardless of their role or the Group entity in which they work, contributes to a mission that goes beyond financial performance alone.

We aim to build a business that creates value, develops skills, generates skilled employment and makes a lasting contribution to improving population health. Every leader is accountable for their decisions, the responsible use of resources and the results achieved.

Our success will be measured as much by our industrial and economic performance as by our impact on African healthcare systems.

Founding Charter, Vision 2030

A Message from the Founder

Portrait of Dr Hervé Oulai, Founder of OVECH Capital

"I firmly believe that Africa has the talent, resources and capabilities required to build a strong and competitive pharmaceutical industry.

With OVECH Capital, our ambition is not merely to develop a prosperous business. We want to build an industrial healthcare group capable of becoming one of Africa's benchmarks.

We were born in Côte d'Ivoire, but our horizon is Africa.

This ambition demands hard work, discipline, integrity, boldness and an unwavering pursuit of excellence from each of us.

I hope that together we will build a company of which future generations can be proud."

Dr Hervé OULAI Founder and General Administrator, OVECH Capital

"Industrial excellence in the service of African health."

Join the vision of a sovereign continent

Would you like to learn more about OVECH Capital, CPF, or explore partnership opportunities with Dr Hervé Oulai?

Get in touch See the career